OAKLAND, Calif. and TORONTO, ON, Dec. 24, 2020 /CNW/ – Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, announced today that it has granted options (each, an “Option”) to purchase an aggregate of 840,000 subordinate voting shares of the Company (“SVS”) to certain directors of the Company. Each Option is exercisable into one SVS in the capital of the Company at an exercise price of $1.83 per SVS. The Options will expire five years from the date of grant and are subject to vesting conditions. All Options were granted in accordance with Harborside’s equity incentive plan adopted by the board of directors of the Company on June 30, 2020 and approved by shareholders on November 24, 2020 (the “Plan”). A copy of the Plan is available under the Company’s SEDAR profile at www.sedar.com.
For the latest news, activities, and media coverage, please visit the Harborside corporate website at http://www.investharborside.com or connect with us on LinkedIn, Facebook, and Twitter.
About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
